The University of Southampton
University of Southampton Institutional Repository

Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial

Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial
Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial

Objective: to assess whether an easy-to-use multifaceted intervention for children presenting to primary care with respiratory tract infections would reduce antibiotic dispensing, without increasing hospital admissions for respiratory tract infection. 

Design: two arm randomised controlled trial clustered by general practice, using routine outcome data, with qualitative and economic evaluations. 

Setting: English primary care practices using the EMIS electronic medical record system. Participants: Children aged 0-9 years presenting with respiratory tract infection at 294 general practices, before and during the covid-19 pandemic.

Intervention: elicitation of parental concerns during consultation; a clinician focused prognostic algorithm to identify children at very low, normal, or elevated 30 day risk of hospital admission accompanied by antibiotic prescribing guidance; and a leaflet for carers including safety netting advice. 

Main outcome measures: rate of dispensed amoxicillin and macrolide antibiotics (superiority comparison) and hospital admissions for respiratory tract infection (non-inferiority comparison) for children aged 0-9 years over 12 months (same age practice list size as denominator). 

Results: of 310 practices needed, 294 (95%) were randomised (144 intervention and 150 controls) representing 5% of all registered 0-9 year olds in England. Of these, 12 (4%) subsequently withdrew (six owing to the pandemic). Median intervention use per practice was 70 (by a median of 9 clinicians). No evidence was found that antibiotic dispensing differed between intervention practices (155 (95% confidence interval 138 to 174) items/year/1000 children) and control practices (157 (140 to 176) items/year/1000 children) (rate ratio 1.011, 95% confidence interval 0.992 to 1.029; P=0.25). Pre-specified subgroup analyses suggested reduced dispensing in intervention practices with fewer prescribing nurses, in single site (compared with multisite) practices, and in practices located in areas of lower socioeconomic deprivation, which may warrant future investigation. Pre-specified sensitivity analysis suggested reduced dispensing among older children in the intervention arm (P=0.03). A post hoc sensitivity analysis suggested less dispensing in intervention practices before the pandemic (rate ratio 0.967, 0.946 to 0.989; P=0.003). The rate of hospital admission for respiratory tract infections in the intervention practices (13 (95% confidence interval 10 to 18) admissions/1000 children) was non-inferior compared with control practices (15 (12 to 20) admissions/1000 children) (rate ratio 0.952, 0.905 to 1.003). 

Conclusions: this multifaceted antibiotic stewardship intervention for children with respiratory tract infections did not reduce overall antibiotic dispensing or increase respiratory tract infection related hospital admissions. Evidence suggested that in some subgroups and situations (for example, under non-pandemic conditions) the intervention slightly reduced prescribing rates but not in a clinically relevant way. 

Trial registration: ISRCTN11405239ISRCTN registry ISRCTN11405239

Humans, Child, Adolescent, Anti-Bacterial Agents/therapeutic use, Cough/drug therapy, Pandemics, COVID-19, Respiratory Tract Infections/drug therapy, Primary Health Care
0959-8146
e072488
Blair, Peter S.
3d5e258e-a342-4f3f-98a3-195267ee7456
Young, Grace
8aa3396b-108e-48a6-8a78-b8217922c902
Clement, Clare
d7ce5b3a-6b2b-478c-a506-982fedeb96d4
Dixon, P.
104f4dc6-1c4a-4875-863c-c719a587857d
Seume, Penny
7f80f3bc-faff-4f49-a74d-bd1a6d795ac4
Ingram, Jenny
91249a1e-26fa-4552-bdbd-b5ba3e19232e
Taylor, Jodi
875cc40a-d428-4a7d-9ee0-710051549a88
Cabral, Christie
e45df99c-4e9a-4d55-b9f0-923ee4b2a506
Lucas, Patricia J.
1d64fb4f-1f3c-4337-bab2-03c98d24bf79
Beech, Elizabeth
9fde70f1-87f8-40e7-8275-d33b371477ec
Horwood, Jeremy
17a93c97-cc9f-4914-ab17-9fdb7dc034e4
Gulliford, Martin
f6866310-c305-464b-92e2-e69bed8d55ef
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Creavin, Sam
c16d369a-6a2d-4c8e-b65a-9d71924fa825
Lane, Janet A.
603b7a39-09bb-4e83-9c6c-67cd19f0e507
Bevan, Scott
17d7f981-f586-46ee-b13c-70f4b4599718
Hay, Alistair D.
981450c6-76fc-44ea-b4b8-1063059d2e80
Blair, Peter S.
3d5e258e-a342-4f3f-98a3-195267ee7456
Young, Grace
8aa3396b-108e-48a6-8a78-b8217922c902
Clement, Clare
d7ce5b3a-6b2b-478c-a506-982fedeb96d4
Dixon, P.
104f4dc6-1c4a-4875-863c-c719a587857d
Seume, Penny
7f80f3bc-faff-4f49-a74d-bd1a6d795ac4
Ingram, Jenny
91249a1e-26fa-4552-bdbd-b5ba3e19232e
Taylor, Jodi
875cc40a-d428-4a7d-9ee0-710051549a88
Cabral, Christie
e45df99c-4e9a-4d55-b9f0-923ee4b2a506
Lucas, Patricia J.
1d64fb4f-1f3c-4337-bab2-03c98d24bf79
Beech, Elizabeth
9fde70f1-87f8-40e7-8275-d33b371477ec
Horwood, Jeremy
17a93c97-cc9f-4914-ab17-9fdb7dc034e4
Gulliford, Martin
f6866310-c305-464b-92e2-e69bed8d55ef
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Creavin, Sam
c16d369a-6a2d-4c8e-b65a-9d71924fa825
Lane, Janet A.
603b7a39-09bb-4e83-9c6c-67cd19f0e507
Bevan, Scott
17d7f981-f586-46ee-b13c-70f4b4599718
Hay, Alistair D.
981450c6-76fc-44ea-b4b8-1063059d2e80

Blair, Peter S., Young, Grace, Clement, Clare, Dixon, P., Seume, Penny, Ingram, Jenny, Taylor, Jodi, Cabral, Christie, Lucas, Patricia J., Beech, Elizabeth, Horwood, Jeremy, Gulliford, Martin, Francis, Nick A., Creavin, Sam, Lane, Janet A., Bevan, Scott and Hay, Alistair D. (2023) Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial. BMJ, 381, e072488, [e072488]. (doi:10.1136/bmj-2022-072488).

Record type: Article

Abstract

Objective: to assess whether an easy-to-use multifaceted intervention for children presenting to primary care with respiratory tract infections would reduce antibiotic dispensing, without increasing hospital admissions for respiratory tract infection. 

Design: two arm randomised controlled trial clustered by general practice, using routine outcome data, with qualitative and economic evaluations. 

Setting: English primary care practices using the EMIS electronic medical record system. Participants: Children aged 0-9 years presenting with respiratory tract infection at 294 general practices, before and during the covid-19 pandemic.

Intervention: elicitation of parental concerns during consultation; a clinician focused prognostic algorithm to identify children at very low, normal, or elevated 30 day risk of hospital admission accompanied by antibiotic prescribing guidance; and a leaflet for carers including safety netting advice. 

Main outcome measures: rate of dispensed amoxicillin and macrolide antibiotics (superiority comparison) and hospital admissions for respiratory tract infection (non-inferiority comparison) for children aged 0-9 years over 12 months (same age practice list size as denominator). 

Results: of 310 practices needed, 294 (95%) were randomised (144 intervention and 150 controls) representing 5% of all registered 0-9 year olds in England. Of these, 12 (4%) subsequently withdrew (six owing to the pandemic). Median intervention use per practice was 70 (by a median of 9 clinicians). No evidence was found that antibiotic dispensing differed between intervention practices (155 (95% confidence interval 138 to 174) items/year/1000 children) and control practices (157 (140 to 176) items/year/1000 children) (rate ratio 1.011, 95% confidence interval 0.992 to 1.029; P=0.25). Pre-specified subgroup analyses suggested reduced dispensing in intervention practices with fewer prescribing nurses, in single site (compared with multisite) practices, and in practices located in areas of lower socioeconomic deprivation, which may warrant future investigation. Pre-specified sensitivity analysis suggested reduced dispensing among older children in the intervention arm (P=0.03). A post hoc sensitivity analysis suggested less dispensing in intervention practices before the pandemic (rate ratio 0.967, 0.946 to 0.989; P=0.003). The rate of hospital admission for respiratory tract infections in the intervention practices (13 (95% confidence interval 10 to 18) admissions/1000 children) was non-inferior compared with control practices (15 (12 to 20) admissions/1000 children) (rate ratio 0.952, 0.905 to 1.003). 

Conclusions: this multifaceted antibiotic stewardship intervention for children with respiratory tract infections did not reduce overall antibiotic dispensing or increase respiratory tract infection related hospital admissions. Evidence suggested that in some subgroups and situations (for example, under non-pandemic conditions) the intervention slightly reduced prescribing rates but not in a clinically relevant way. 

Trial registration: ISRCTN11405239ISRCTN registry ISRCTN11405239

Text
bmj-2022-072488.full - Version of Record
Available under License Creative Commons Attribution.
Download (506kB)

More information

Accepted/In Press date: 15 March 2023
e-pub ahead of print date: 26 April 2023
Published date: 26 April 2023
Additional Information: Funding Information: Funding: This research is funded by the NIHR Health Technology Assessment programme (funder ref: 16/31/98, ISRCTN11405239 ). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. The funders had no role in considering the study design or in the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the article for publication. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
Keywords: Humans, Child, Adolescent, Anti-Bacterial Agents/therapeutic use, Cough/drug therapy, Pandemics, COVID-19, Respiratory Tract Infections/drug therapy, Primary Health Care

Identifiers

Local EPrints ID: 477421
URI: http://eprints.soton.ac.uk/id/eprint/477421
ISSN: 0959-8146
PURE UUID: 7f02f2cf-da17-40f3-b8ab-b2a0294930b9
ORCID for Nick A. Francis: ORCID iD orcid.org/0000-0001-8939-7312

Catalogue record

Date deposited: 06 Jun 2023 16:55
Last modified: 06 Jun 2024 02:07

Export record

Altmetrics

Contributors

Author: Peter S. Blair
Author: Grace Young
Author: Clare Clement
Author: P. Dixon
Author: Penny Seume
Author: Jenny Ingram
Author: Jodi Taylor
Author: Christie Cabral
Author: Patricia J. Lucas
Author: Elizabeth Beech
Author: Jeremy Horwood
Author: Martin Gulliford
Author: Nick A. Francis ORCID iD
Author: Sam Creavin
Author: Janet A. Lane
Author: Scott Bevan
Author: Alistair D. Hay

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×